Cas:959238-63-2 {1-[(Methylamino)methyl]cyclopropyl}methanol manufacturer & supplier

Chemical Name:{1-[(Methylamino)methyl]cyclopropyl}methanol

CAS.NO:959238-63-2

Synonyms:{1-[(Methylamino)methyl]cyclopropyl}methanol;Cyclopropanemethanol, 1-[(methylamino)methyl]-;[1-[(Methylamino)methyl]cyclopropyl]methanol

Molecular Formula:C₆H₁₃NO

Molecular Weight:115.174

HS Code:2922199090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:168.1±13.0 °C at 760 mmHg

Density:1.0±0.1 g/cm3

Index of Refraction:1.476

PSA:32.26000

Exact Mass:115.099716

LogP:-0.70

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like {1-[(Methylamino)methyl]cyclopropyl}methanol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,[1-[(Methylamino)methyl]cyclopropyl]methanol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,{1-[(Methylamino)methyl]cyclopropyl}methanol Use and application,Cyclopropanemethanol, 1-[(methylamino)methyl]- technical grade,usp/ep/jp grade.

Related News: China will use its national drug bulk-buy scheme to lower the price of drugs currently sold at higher prices compared with other markets, it said in an official statement. {1-[(Methylamino)methyl]cyclopropyl}methanol manufacturer Johnson & Johnson’s Darzalex has comfortably been the only CD38 multiple myeloma drug on the market for years until Sanofi hit the scene last year with Sarclisa. Now, just as the competition’s slated to intensify, the U.S. company is building its case with new patient survival data. {1-[(Methylamino)methyl]cyclopropyl}methanol supplier On Friday, the Trump administration announced it will deny entry to foreign nationals who have traveled in China in the last 14 days, starting Sunday. {1-[(Methylamino)methyl]cyclopropyl}methanol vendor China will use its national drug bulk-buy scheme to lower the price of drugs currently sold at higher prices compared with other markets, it said in an official statement. {1-[(Methylamino)methyl]cyclopropyl}methanol factory Johnson & Johnson’s Darzalex has comfortably been the only CD38 multiple myeloma drug on the market for years until Sanofi hit the scene last year with Sarclisa. Now, just as the competition’s slated to intensify, the U.S. company is building its case with new patient survival data.